Lumentum slides 13% as all-stock Marvell deal slammed as fiduciary malpractice
firstadopter · x · 2026-11-03
Investor firstadopter harshly criticized Lumentum's all-stock, no-cash merger deal with Marvell, calling it "fiduciary malpractice" for Lumentum shareholders — no cash consideration means no downside protection. The stock fell 13.19% to $729.77 (down $110.93) on the news, showing the market's instant verdict on the structure.
More from Venture
- X integrates Interactive Brokers: trade stocks and crypto directly from the timeline — RachelVT42 · 2026-11-03
- Zynga founder Mark Pincus distilled into 19 rules: instincts are right 95%, ideas only 25% — aakashgupta · 2026-11-03
- Wispr Flow raised $280M Series B at $2B valuation ahead of fireside chat — adityaag · 2026-11-03
- S&P cuts Meta outlook to negative, warns leverage could top 1.0x by 2027 on AI capex — fortune · 2026-11-03
- Anthropic's amended S-1 shows Q3 compute costs up 78% QoQ vs 47% revenue growth — GaryMarcus · 2026-11-03
- Polymarket gives OpenAI a 46% chance of IPO before Q3 2027 — Polymarket · 2026-11-03